Orbimed Advisors LLC Third Harmonic Bio, Inc. Transaction History
Orbimed Advisors LLC
- $4.24 Billion
- Q3 2024
A detailed history of Orbimed Advisors LLC transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 5,779,071 shares of THRD stock, worth $70.2 Million. This represents 1.85% of its overall portfolio holdings.
Number of Shares
5,779,071
Previous 5,779,071
-0.0%
Holding current value
$70.2 Million
Previous $75.1 Million
4.23%
% of portfolio
1.85%
Previous 1.81%
Shares
1 transactions
Others Institutions Holding THRD
# of Institutions
83Shares Held
43.6MCall Options Held
7.1KPut Options Held
0-
Atlas Venture Life Science Advisors, LLC10.9MShares$133 Million18.24% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$53 Million1.88% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.18MShares$38.7 Million1.87% of portfolio
-
General Atlantic LLC New York, NY2.96MShares$35.9 Million1.15% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.83MShares$34.4 Million0.02% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $490M